Viking Therapeutics Stock Market Value
| VKTX Stock | USD 30.89 1.16 3.90% |
| Symbol | Viking |
Viking Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Viking Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viking Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viking Therapeutics.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Viking Therapeutics on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Viking Therapeutics or generate 0.0% return on investment in Viking Therapeutics over 90 days. Viking Therapeutics is related to or competes with Terns Pharmaceuticals, Akero Therapeutics, Madrigal Pharmaceuticals, Sarepta Therapeutics, PTC Therapeutics, Axsome Therapeutics, and Seres Therapeutics. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for... More
Viking Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viking Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viking Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 24.65 | |||
| Value At Risk | (10.98) | |||
| Potential Upside | 8.39 |
Viking Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viking Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viking Therapeutics' standard deviation. In reality, there are many statistical measures that can use Viking Therapeutics historical prices to predict the future Viking Therapeutics' volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.55) | |||
| Total Risk Alpha | 0.0204 | |||
| Treynor Ratio | (0.92) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viking Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viking Therapeutics Backtested Returns
Viking Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.1, which indicates the firm had a -0.1 % return per unit of risk over the last 3 months. Viking Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Viking Therapeutics' Risk Adjusted Performance of (0.1), coefficient of variation of (837.81), and Variance of 26.59 to confirm the risk estimate we provide. The entity has a beta of 0.68, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Viking Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Viking Therapeutics is expected to be smaller as well. At this point, Viking Therapeutics has a negative expected return of -0.54%. Please make sure to validate Viking Therapeutics' value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Viking Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.70 |
Good predictability
Viking Therapeutics has good predictability. Overlapping area represents the amount of predictability between Viking Therapeutics time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viking Therapeutics price movement. The serial correlation of 0.7 indicates that around 70.0% of current Viking Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 3.99 |
Viking Therapeutics lagged returns against current returns
Autocorrelation, which is Viking Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Viking Therapeutics' stock expected returns. We can calculate the autocorrelation of Viking Therapeutics returns to help us make a trade decision. For example, suppose you find that Viking Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Viking Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Viking Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Viking Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Viking Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Viking Therapeutics Lagged Returns
When evaluating Viking Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Viking Therapeutics stock have on its future price. Viking Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Viking Therapeutics autocorrelation shows the relationship between Viking Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Viking Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.